Esperion Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ESPR
Share price (6/2/26): $3.14
Market cap (6/2/26): $808 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from DEFA14A 122 pages Agreement and Plan of Merger by and Among Essence Parent Inc., Essence Mergerco Inc., and Esperion Therapeutics, Inc. Dated as of May 1, 2026

from 8-K 122 pages Agreement and Plan of Merger by and Among Essence Parent Inc., Essence Mergerco Inc., and Esperion Therapeutics, Inc. Dated as of May 1, 2026

from 8-K 132 pages Agreement and Plan of Merger by and Among Corstasis Therapeutics Inc., Esperion Therapeutics, Inc., Cirrus Transaction Subsidiary, Inc., Benjamin Esque, in the Capacities Described Herein, and the Representative Named Herein March 2, 2026